Fundamental Data for IPXL

Impax Laboratories, Inc. is a specialty pharmaceutical company focused on the development and commercialization of specialty generic and branded pharmaceuticals, utilizing in-house development and formulation expertise.

# Employees: 453

Address: 30831 Huntwood Avenue,Hayward,CA,USA

Phone: 510 476-2000

Fax: 215 807-0230

Website: www.impaxlabs.com

Email: invest@impaxlabs.com

Sector: Medical

Industry: MED-GENERIC DRG

Executive Officers

Charles Hsiao (Chmn.; Dir.)

Larry Hsu (Pres.; Dir.)

David S. Doll (Sr. V.P.; Sales & Marketing)

Barry R. Edwards (C.E.O.; Dir.)

May Chu (V.P.; Quality Affairs,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/25/2010

Mean EPS (Next Qtr): $0.11

Mean EPS (Year): $0.30

Mean Estimate(Long Term): $39.49

P/E Ratio(Based on EPS estimate): 38.260

Number of Estimates: 3

Shares Performance

Period	IPXL	Compare to S&P
YTD	-0.01 %	-0.01 %
4 Weeks	27.82 %	21.34 %
12 Weeks	41.88 %	32.12 %

Shares Information

Analyst Coverage: Y

Avg Volume: 382068

Shares Outstanding: 61M

Market Cap: $0.70B

52 Week High: $11.56

52 Week Low: $4.75

P/E Ratio: 31.530

PEG Ratio: 0.970

Split: On 1/1/1990 IPXL split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 120.00 %

EPS Growth in Last Year: 173.33 %

Sales Growth in Last Quarter: 11.18 %

Sales Growth in Last Quarter: 76.61 %

Financials

Qtr Book Value: $3.86

Cash Flow/Share: $10.22

Change in Payout Ratio: 0.000

Price/Sales: 3.080